Dear all
if you are interested, you might try to get access to the
recording.
not very much new, key message of Bayer: If we have patents, we
can share. and: we need innovation.
Heli from EPO failed to take part in the discussion (technical
problems).
I guess most was relevant for IP protection of Genome Edited
Seeds.
Interestingly, concerns were raised by on expert on the Unitary
patent.
For me most relevant will be to try to get in contact with the
expert from EU Commission at beginning of next year.
Cheers
Christoph
| Betreff: | Today’s EURACTIV debate - thank you and follow-up materials |
|---|---|
| Datum: | Thu, 17 Dec 2020 11:25:21 +0100 |
| Von: | Tamara Novel <tamara.novel@euractiv.com> |
| An: | Simona Ovesea <simona.ovesea@euractiv.com> |
Kind regards,